ATE523204T1 - Cd44v6-peptide als bakterielle infektionsinhibitoren - Google Patents

Cd44v6-peptide als bakterielle infektionsinhibitoren

Info

Publication number
ATE523204T1
ATE523204T1 AT09002149T AT09002149T ATE523204T1 AT E523204 T1 ATE523204 T1 AT E523204T1 AT 09002149 T AT09002149 T AT 09002149T AT 09002149 T AT09002149 T AT 09002149T AT E523204 T1 ATE523204 T1 AT E523204T1
Authority
AT
Austria
Prior art keywords
bacterial infection
spp
infection inhibitors
cd44v6 peptides
cd44v6
Prior art date
Application number
AT09002149T
Other languages
English (en)
Inventor
Christian Jung
Alexandra Matzke
Veronique Orian-Rousseau
Helmut Ponta
Original Assignee
Karlsruher Inst Technologie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karlsruher Inst Technologie filed Critical Karlsruher Inst Technologie
Application granted granted Critical
Publication of ATE523204T1 publication Critical patent/ATE523204T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/178—Lectin superfamily, e.g. selectins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70585—CD44
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT09002149T 2009-02-16 2009-02-16 Cd44v6-peptide als bakterielle infektionsinhibitoren ATE523204T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09002149A EP2218457B1 (de) 2009-02-16 2009-02-16 CD44v6-Peptide als bakterielle Infektionsinhibitoren

Publications (1)

Publication Number Publication Date
ATE523204T1 true ATE523204T1 (de) 2011-09-15

Family

ID=40834558

Family Applications (1)

Application Number Title Priority Date Filing Date
AT09002149T ATE523204T1 (de) 2009-02-16 2009-02-16 Cd44v6-peptide als bakterielle infektionsinhibitoren

Country Status (3)

Country Link
US (2) US20100305026A1 (de)
EP (1) EP2218457B1 (de)
AT (1) ATE523204T1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201220889D0 (en) 2012-11-21 2013-01-02 Kit Karlsrusher Inst Fuer Technologie Und Inst Fuer Toxikologie Und Genetik And Amcure Gmbh CD44v6-derived peptides for treating metastasizing cancers
GB201220899D0 (en) * 2012-11-21 2013-01-02 Kit Karlsrusher Inst Fuer Technologie Und Inst Fuer Toxikologie Und Genetik And Amcure Gmbh CD44v6-derived pegylated peptides
GB201220891D0 (en) * 2012-11-21 2013-01-02 Kit Karlsrusher Inst Fuer Technologie Und Inst Fuer Toxikologie Und Genetik And Amcure Gmbh CD44v6-derived peptides for treating breast cancers
GB201220901D0 (en) * 2012-11-21 2013-01-02 Kit Karlsrusher Inst Fuer Technologie Und Inst Fuer Toxikologie Und Genetik And Amcure Gmbh CD44v6-derived peptides for treating pancreatic cancer
GB201421647D0 (en) 2014-12-05 2015-01-21 Amcure Gmbh And Ruprecht-Karls-Universitat And Karlsruher Institut F�R Technologie CD44v6-derived cyclic peptides for treating cancers and angiogenesis related diseases
EP4464714A1 (de) 2023-05-19 2024-11-20 Karlsruher Institut für Technologie Screening-verfahren für zellreproliferierende peptide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002521058A (ja) * 1998-07-27 2002-07-16 マイクロビアル テクニクス リミティッド 肺炎連鎖球菌由来の核酸及びタンパク質
JP2007525157A (ja) * 2003-04-15 2007-09-06 インターツェル・アクチェンゲゼルシャフト 肺炎連鎖球菌抗原
EP1647556B1 (de) 2004-10-14 2010-05-19 Karlsruher Institut für Technologie Peptidische Verbindungen und deren Ableitungen für die Behandllung von menschlichen Krankheiten durch Hemmung der Signalübertragung über Wachstumfaktoren
GB0714963D0 (en) * 2007-08-01 2007-09-12 Novartis Ag Compositions comprising antigens

Also Published As

Publication number Publication date
EP2218457B1 (de) 2011-09-07
EP2218457A1 (de) 2010-08-18
US20100305026A1 (en) 2010-12-02
US8933017B2 (en) 2015-01-13
US20130072423A1 (en) 2013-03-21

Similar Documents

Publication Publication Date Title
CY1123052T1 (el) Συνθεσεις και μεθοδοι σχετικες με παραλλαγες της πρωτεϊνες α (spa)
NZ618571A (en) Peptides and their use
ATE523204T1 (de) Cd44v6-peptide als bakterielle infektionsinhibitoren
WO2012003474A3 (en) Compositions and methods related to protein a (spa) variants
AU2008334326A8 (en) Recombinant bacteriophage for detection of nosocomial infection
RU2016111360A (ru) Пептидомиметические макроциклы
ZA201009074B (en) Axmi-115,axmi-113,axmi-005,axmi-163 and axmi-184:vip3a insecticidal proteins from bacillus thuringiensis and methods for their use
IN2012DN00829A (de)
EP2730576A3 (de) Antiinfektiöse Verbindungen
CL2012001080A1 (es) Dispersión sólida de rifaximina y un portador farmacéuticamente aceptable; composición farmacéutica; uso en el tratarmiento y/o prevención de una infecciíon microbiana que comprende la administración de la dipersión sólida.
MX2010008632A (es) Leptina-polipeptidos modificados y sus usos.
MY179933A (en) Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use thereof
DK2303044T3 (da) Dragt til rent rum og lignende
SG10201809286XA (en) Biologically active peptides
IN2012DN02624A (de)
MX356959B (es) Cepa paenibacillus alvei ts-15 y su uso en el control de organismos patogenicos.
GB201009861D0 (en) OMV vaccines
WO2010124097A3 (en) Transcription factor modulating compounds and methods of use thereof
HK1198122A1 (en) Eosinophil peroxidase compositions and methods of their use
WO2010134827A9 (en) Extended acting oxygen generating composition for treating microbial infections
MX2012004622A (es) Adyuvante para vacunas, vacunas que lo comprenden y usos.
NZ595528A (en) Sparc angiogenic domain and methods of use
GB201005545D0 (en) Transcription factor decoys
EP2408812A4 (de) Immunmodulatorische verfahren und systeme zur behandlung und/oder prävention von atherosklerose sowie zugehörige proteine, peptide und zusammensetzungen
MY151307A (en) Peptides having antimicrobial activity

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties